Ablevia biotech GmbH
Back to list
Facts
- Founded
- 2018
- Staff
- 4
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
Ablevia develops a new class of infusible therapeutics to selectively remove harmful and disease-causing antibodies. These therapeutics can be readily adapted to target unwanted antibodies in rare diseases or in conditions with unmet clinical needs. Founded in 2018 at the Vienna Biocenter Campus, Ablevia focuses on IP generation and preclinical research and development.
R&D:Ablevia focusses on research and development of therapeutics for the selective removal of disease-causing and harmful anitbodies in autoimmune diseases or neutralizing anti-drug anitbodies.
Similar companies in RDM biotech/pharma
EVER Neuro Pharma GmbH
- Organization type
- RDM biotech/pharma
- Region
- Upper Austria
- Focus
- human health
emergentec biodevelopment GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- bioinformatics
OncoOne Research
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Focus
- human health
Novartis Pharma GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health